ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,125
0,43%
Bitcoin
64 059,03
0,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) Actualités

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:PVCT
DateHeureSourceTitreSymboleSociété
29/02/202415h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/02/202415h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/11/202317h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/06/202315h46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/06/202300h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202321h19Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202320h42Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202322h53Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/05/202319h59Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/202320h43Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/03/202315h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/12/202214h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/10/202219h30Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/03/202222h05Edgar (US Regulatory)Annual Report (10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
25/11/202019h09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/201922h50Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201721h11Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201719h58Edgar (US Regulatory)(25-NSE)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/04/201723h17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/04/201723h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/03/201712h05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/03/201721h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/03/201712h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
31/01/201712h23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/01/201712h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
26/01/201723h16Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
05/10/201623h26Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
26/08/201612h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/07/201622h49Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
13/05/201622h09Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

Dernières Valeurs Consultées

EU
PX1
CAC 40
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
EU
VIV
Vivendi
NYSE
JPM
JP Morgan Chase
EU
VK
Vallourec
NYSE
DIS
Walt Disney
EU
ORA
Orange
NASDAQ
AMZN
Amazon.com
EU
ML
Michelin
EU
RNO
Renault
EU
RI
Pernod Ricard
EU
AI
Air Liquide
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés